Literature DB >> 20571146

Increased presence of stromal myofibroblasts and tenascin-C with malignant progression in canine mammary tumors.

H Yoshimura1, M Michishita, K Ohkusu-Tsukada, K Takahashi.   

Abstract

The aims of this study were to determine whether the appearance of stromal myofibroblasts and the expression of tenascin-C (Tn-C) correlate with the grade of malignancy in canine mammary tumors and to determine the main cellular source of Tn-C in these tumors. Single or double immunostaining using antibodies against α-smooth muscle actin (α-SMA) and Tn-C was performed on serial sections of normal canine mammary glands as well as those with lobular hyperplasia, simple adenoma, and simple carcinoma. Thirty-nine of 42 simple carcinomas (93%) exhibited stromal α-SMA-positive myofibroblasts and Tn-C expression. Only 6 of 11 cases of simple adenoma (55%) showed these changes, whereas no changes were observed in normal mammary gland tissue or cases of lobular hyperplasia. The distribution of stromal Tn-C correlated with the presence of myofibroblasts. However, Tn-C immunoreactivity was also occasionally observed in the basement membrane zone surrounding the myoepithelial layer in normal tissue, benign lesions, and tubulopapillary carcinomas. This pattern of staining was not related to the presence of myofibroblasts. The appearance of stromal myofibroblasts and expression of Tn-C were significantly correlated with higher histological grades of malignancy and vascular/lymphatic invasion in simple carcinomas. Stromal myofibroblasts appear to be a major cellular source of Tn-C and play an important role in the development of canine mammary tumors. The Tn-C expressed in the basement membrane zone of normal, hyperplastic, and neoplastic mammary tissue, which is likely produced by neighboring myoepithelial cells, may differ functionally from the Tn-C produced by myofibroblasts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571146     DOI: 10.1177/0300985810369901

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  8 in total

1.  Matrix metalloproteinases and their inhibitors in canine mammary tumors.

Authors:  Luca Aresu; Mery Giantin; Emanuela Morello; Marta Vascellari; Massimo Castagnaro; Rosa Lopparelli; Vanessa Zancanella; Anna Granato; Spiridione Garbisa; Arianna Aricò; Alice Bradaschia; Franco Mutinelli; Mauro Dacasto
Journal:  BMC Vet Res       Date:  2011-07-04       Impact factor: 2.741

2.  Histological and immunohistochemical evaluation of stroma variations and their correlation with the Ki-67 index and expressions of glucose transporter 1 and monocarboxylate transporter 1 in canine thyroid C-cell carcinomas.

Authors:  Yoshio Kawamura; Hiroko Mizooku; Minoru Okamoto; Kazuya Matsuda; Tetsuo Omachi; Kazuko Hirayama; Tsuyoshi Kadosawa; Hiroyuki Taniyama
Journal:  J Vet Med Sci       Date:  2016-01-03       Impact factor: 1.267

3.  MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.

Authors:  Malgorzata Bulkowska; Agata Rybicka; Kerem Mert Senses; Katarzyna Ulewicz; Katarzyna Witt; Joanna Szymanska; Bartlomiej Taciak; Robert Klopfleisch; Eva Hellmén; Izabella Dolka; Ali O Gure; Joanna Mucha; Mariusz Mikow; Slawomir Gizinski; Magdalena Krol
Journal:  BMC Cancer       Date:  2017-11-07       Impact factor: 4.430

4.  Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma.

Authors:  Ashley Case; Becky K Brisson; Amy C Durham; Suzanne Rosen; James Monslow; Elizabeth Buza; Pascale Salah; Julie Gillem; Gordon Ruthel; Sridhar Veluvolu; Veronica Kristiansen; Ellen Puré; Dorothy C Brown; Karin U Sørenmo; Susan W Volk
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

5.  Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.

Authors:  Julia Ettlin; Elena Clementi; Parisa Amini; Alexandra Malbon; Enni Markkanen
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

Review 6.  Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors.

Authors:  Enni Markkanen
Journal:  Front Cell Dev Biol       Date:  2019-12-17

7.  Collagen molecular phenotypic switch between non-neoplastic and neoplastic canine mammary tissues.

Authors:  Masahiko Terajima; Yuki Taga; Becky K Brisson; Amy C Durham; Kotaro Sato; Katsuhiro Uzawa; Tomoaki Saito; Shunji Hattori; Karin U Sørenmo; Mitsuo Yamauchi; Susan W Volk
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.996

8.  Differential stromal reprogramming in benign and malignant naturally occurring canine mammary tumours identifies disease-modulating stromal components.

Authors:  Parisa Amini; Sina Nassiri; Alexandra Malbon; Enni Markkanen
Journal:  Sci Rep       Date:  2020-03-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.